References
RA Fisken DA Heath AM Bold (1980) ArticleTitleHypercalcemia-a hospital survey. Quart J Med 49 405–418 Occurrence Handle1:STN:280:Bi6B2szoslU%3D Occurrence Handle7022540
JP Bilezikian (2000) ArticleTitlePrimary hyperparathyroidism. When to observe and when to operate. Endocrinol Metab Clin North Am 29 465–478
JA Kanis RGG Russell (1977) ArticleTitleRate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its one alpha hydroxylated derivatives. Br Med J 1 78–81 Occurrence Handle1:STN:280:CSiD1cfmtFU%3D Occurrence Handle832019
AM Parfitt (1987) ArticleTitleBone and plasma calcium homeostasis. Bone 8 S1–S8
AF Stewart RL Horst LJ Deftos EC Cadman R Lang AE Broadus (1980) ArticleTitleBiochemical evaluation of patients with cancer-associated hypercalcemia. N Engl J Med 303 1377–1383 Occurrence Handle1:STN:280:Bi6D2M3htlE%3D Occurrence Handle6253785
SH Ralston I Fogelman MD Gardner FJ Dryburgh RA Cowan IT Boyle (1984) ArticleTitleHypercalcemia of malignancy: evidence for a non-parathyroid humoral mediator with an effect on renal tubular calcium handling. Clin Sci 66 187–191 Occurrence Handle1:STN:280:BiuC3cjkt1I%3D Occurrence Handle6692653
SH Ralston I Fogelman MD Gardner IT Boyle (1984) ArticleTitleRelative contribution of humoral and metastatic factors to the pathogenesis of hypercalcemia in malignancy. Br Med J 288 812–813
C Isales ML Carcangui AF Stewart (1987) ArticleTitleHypercalcemia in breast cancer: a re-evaluation. Am J Med 82 1143–1147 Occurrence Handle1:STN:280:BiiB28jms1M%3D Occurrence Handle3037897
TJ Martin LJ Suva (1989) ArticleTitleParathyroid hormone-related protein in hypercalcemia of malignancy. Clin Endocrinol 31 631–647 Occurrence Handle1:CAS:528:DyaK3cXhvFCgtA%3D%3D
V Grill P Ho JJ Body N Johanson SC Kukreja JM Moseley TJ Martin (1991) ArticleTitleParathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73 1309–1315
WJ Burtis TJ Brady JJ Orloff JB Ersbak RP Warrell BR Olson TL Wu ME Mitnick AE Broadus AF Stewart (1990) ArticleTitleImmunochemical characterisation of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of malignancy. N Engl J Med 322 1106–1112 Occurrence Handle1:STN:280:By%2BB3cngtVU%3D Occurrence Handle2320080
BE Kemp JM Moseley CP Rodda et al. (1987) ArticleTitleParathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238 1568–1570 Occurrence Handle1:CAS:528:DyaL1cXnt12lsQ%3D%3D Occurrence Handle3685995
AJ Yates GE Gutierrez P Smolens PS Travis MS Katz TB Aufdemorte BF Boyce TK Hymer JW Poser GR Mundy (1988) ArticleTitleEffects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J Clin Invest 81 932–938 Occurrence Handle1:CAS:528:DyaL1cXhvFyqt7w%3D Occurrence Handle3343349
R Rizzoli JC Pache L Didierjean A Burger JP Bonjour (1994) ArticleTitleA thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab 79 912–915 Occurrence Handle1:STN:280:ByuA2MfhtVA%3D Occurrence Handle8077382
K Yoshimoto R Yamasaki H Sakai U Tezuka M Takahashi M Iizuka T Sekiya S Saito (1989) ArticleTitleEctopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 68 976–981 Occurrence Handle1:STN:280:BiaB3svkslI%3D Occurrence Handle2541161
P Skrabanek J McPartlin D Powell (1980) ArticleTitleTumor hypercalcemia and ectopic hyperparathyroidism. Medicine (Baltimore) 59 262–282 Occurrence Handle1:STN:280:Bi%2BB3s7ns1w%3D
A Shionoiri T Horiuchi T Onouchi H Tsutsumi M Ohta T Hosoi H Ito H Orimo (2000) ArticleTitleHypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma. Intern Med 39 810–813
WA Ratcliffe AC Hutchesson NJ Bundred JG Ratcliffe (1992) ArticleTitleRole of assays for parathyroid hormone-related protein in investigation of hypercalcaemia [see comments]. Lancet 339 164–167 Occurrence Handle10.1016/0140-6736(92)90220-W Occurrence Handle1:STN:280:By2C3cnptlA%3D Occurrence Handle1346019
TA Guise GR Mundy (1998) ArticleTitleCancer and bone [Review]. Endocrine Rev 19 18–54 Occurrence Handle1:STN:280:DyaK1c7lsFyrsQ%3D%3D
JH Han SJ Choi N Kurihara M Koide Y Oba GD Roodman (2001) ArticleTitleMacrophage inflammatory protein-1 alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97 3349–3353 Occurrence Handle10.1182/blood.V97.11.3349 Occurrence Handle1:CAS:528:DC%2BD3MXktFOkt7o%3D Occurrence Handle11369623
SH Ralston RA Cowan MD Gardner WD Fraser E Marshall IT Boyle (1987) ArticleTitleComparison of intestinal calcium absorption and 1,25 dihydroxyvitamin D3 levels in malignancy-associated hypercalcemia and primary hyperparathyroidism. Clin Endocrinol 26 281–291 Occurrence Handle1:STN:280:BieD3c3os1Q%3D
S Fukomoto T Matsumoto K Ikeda et al. (1988) ArticleTitleClinical evaluation of calcium metabolism in adult T-cell leukaemia/lymphoma. Arch Intern Med 148 921–925 Occurrence Handle10.1001/archinte.148.4.921 Occurrence Handle2895617
NA Breslau JL McGuire JE Zerwekh EP Frenkel CYC Pak (1984) ArticleTitleHypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 100 1–7
M Davies ME Hayes EB Mawer GA Lumb (1985) ArticleTitleAbnormal vitamin D metabolism in Hodgkin’s lymphoma. Lancet ii 1186–1188 Occurrence Handle10.1016/S0140-6736(85)92864-8
M Peacock WG Robertson BEC Nordin (1969) ArticleTitleRelation between serum and urinary calcium with particular reference to parathyroid activity. Lancet i 384–386 Occurrence Handle10.1016/S0140-6736(69)91353-1
RA Kaplan MR Haussler LJ Deftos H Bone CY Pak (1977) ArticleTitleThe role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59 756–760 Occurrence Handle1:CAS:528:DyaE2sXktVemt78%3D Occurrence Handle192763
B Buchs R Rizzoli JP Bonjour (1991) ArticleTitleEvaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia. Bone 12 47–56 Occurrence Handle1:CAS:528:DyaK3MXltFWkt7k%3D Occurrence Handle2054236
S Jansson LE Tisell G Lindstedt PA Lundberg (1991) ArticleTitleDisodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism [see comments]. Surgery 110 480–486 Occurrence Handle1:STN:280:By6A287is1Q%3D Occurrence Handle1845370
A Falchetti AE Bale A Amorosi C Bordi P Cicchi S Bandini SJ Marx ML Brandi (1993) ArticleTitleProgression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab 76 139–144 Occurrence Handle1:STN:280:ByyC3s3hsFU%3D Occurrence Handle8421078
JS Adams (1989) ArticleTitleVitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 18 765–778
HJ Zeimer TM Greenaway J Slavin DK Hards H Zhou JC Doery AN Hunter A Duffield TJ Martin V Grill (1998) ArticleTitleParathyroid-hormone-related protein in sarcoidosis. Am J Pathol 152 17–21 Occurrence Handle1:CAS:528:DyaK1cXktlygsA%3D%3D Occurrence Handle9422518
EB Mawer JT Hann JL Berry et al. (1985) ArticleTitleVitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci 68 141–145
GR Mundy JL Shapiro JG Bandelin EM Canalis LG Raisz (1976) ArticleTitleDirect stimulation of bone resorption by thyroid hormones. J Clin Invest 58 529–534 Occurrence Handle1:CAS:528:DyaE28XlsFCht7c%3D Occurrence Handle182721
AF Stewart M Adler CM Byers et al. (1982) ArticleTitleCalcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 306 1136–1140 Occurrence Handle1:STN:280:Bi2C2szgt1A%3D Occurrence Handle6280047
ES Orwoll (1982) ArticleTitleThe milk-alkali syndrome—current concepts. Ann Intern Med 97 242–249
FH Menko OLM Bijvoet JLHH Fronen LM Sandler S Adami JLH O’Riordan W Blomen-Kukenen (1983) ArticleTitleFamilial benign hypercalcemia. Quart J Med 206 120–140
SJ Marx AM Spiegel EM Brown JO Koehler DG Gardner MF Brennan GD Aurbach (1978) ArticleTitleDivalent cation metabolism. Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. Am J Med 65 235–242 Occurrence Handle1:CAS:528:DyaE1cXlt1Oiu7Y%3D Occurrence Handle686009
MR Pollak EM Brown YH Chou SC Hebert SJ Marx B Steinmann T Levi CE Seidman JG Seidman (1993) ArticleTitleMutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 1297–1303 Occurrence Handle1:CAS:528:DyaK2cXhtVCjsbc%3D Occurrence Handle7916660
AM Parfitt (1979) ArticleTitleEquilibrium and disequilibrium hypercalcemia. New light on an old concept. Metab Bone Dis Rel Res 1 279–293
JE Benabe M Martinez-Maldonado (1978) ArticleTitleHypercalcemic nephropathy. Arch Intern Med 138 777–779 Occurrence Handle10.1001/archinte.138.5.777 Occurrence Handle1:CAS:528:DyaE1cXksFOnsLs%3D Occurrence Handle646542
DJ Hosking A Cowley CA Bucknall (1981) ArticleTitleRehydration in the treatment of severe hypercalcaemia. Quart J Med 50 473–481 Occurrence Handle1:STN:280:Bi2C1MfisVM%3D Occurrence Handle7342172
SJ Iqbal M Giles S Ledger N Nanji T Howl (1988) ArticleTitleNeed for albumin adjustments of urgent total serum calcium. Lancet ii 1477–1478 Occurrence Handle10.1016/S0140-6736(88)90945-2
G Merlini LA Fitzpatrick ES Siris et al. (1984) ArticleTitleA human myeloma immunoglobulin G binding four moles of calcium associated with asymptomatic hypercalcemia. J Clin Immunol 4 185–196 Occurrence Handle1:STN:280:BiuB2c%2Fhsl0%3D Occurrence Handle6736208
V Grill RM Murray PW Ho JD Santamaria P Pitt C Potts G Jerums TJ Martin (1992) ArticleTitleCirculating PTH and PTHrP levels before and after treatment of tumor-induced hypercalcemia with pamidronate disodium (APD). J Clin Endocrinol Metab 74 1468–1470 Occurrence Handle1:STN:280:By2B2snkvVc%3D Occurrence Handle1592895
J Hinnie E Bell E McKillop S Gallacher (2001) ArticleTitleThe prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 68 216–218 Occurrence Handle1:CAS:528:DC%2BD3MXktFWhu7k%3D Occurrence Handle11353947
SH Ralston BF Boyce RA Cowan MD Gardner FJ Dryburgh IT Boyle (1986) ArticleTitleHumoral hypercalcemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour. Quart J Med 277 325–335
SH Ralston SJ Gallacher U Patel J Campbell IT Boyle (1990) ArticleTitleCancer-associated hypercalcemia: morbidity and mortality. Ann Intern Med 112 499–504 Occurrence Handle1:STN:280:By%2BC1MnnsFc%3D Occurrence Handle2138442
PJ Ling RP A’Hern JR Hardy (1995) ArticleTitleAnalysis of survival following treatment of tumour-induced hypercalcemia with intravenous pamidronate (APD). Analysis of survival following treatment of tumour-induced hypercalcemia with intravenous pamidronate (APD). Br J Cancer 72 206–209 Occurrence Handle1:STN:280:ByqA383jtV0%3D Occurrence Handle7599053
HIJ Harinck OLM Bijvoet AST Platingh JJ Body JWF Elte HP Sleeboom J Wildiers JP Neijt (1987) ArticleTitleRole of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride. Am J Med 82 1133–1142 Occurrence Handle1:STN:280:BiiB28jms1I%3D Occurrence Handle3300303
SR Heller DJ Hosking (1986) ArticleTitleRenal handling of calcium and sodium in metastatic and non-metastatic malignancy. Br Med J 292 583–586 Occurrence Handle1:STN:280:BimC3s3lt1Y%3D
C Hasling P Charles L Mosekilde (1986) ArticleTitleEtidronate disodium for treating hypercalcemia of malignancy: a double blind, placebo-controlled study. Eur J Clin Invest 16 433–437 Occurrence Handle1:STN:280:BiiC3crlvF0%3D Occurrence Handle3100312
RG Russell PI Croucher MJ Rogers (1999) ArticleTitleBisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int 9 IssueIDsuppl 2 S66–S80 Occurrence Handle10525729
SH Ralston (1992) ArticleTitleMedical management of hypercalcemia [Review]. Br J Clin Pharm 34 11–20 Occurrence Handle1:STN:280:By2A3sfgsVY%3D
SH Ralston SJ Gallacher U Patel FJ Dryburgh WD Fraser RA Cowan IT Boyle (1989) ArticleTitleComparison of three intravenous bisphosphonates in cancer-associated hypercalcemia. Lancet ii 1180–1182 Occurrence Handle10.1016/S0140-6736(89)91791-1
QS Ringerberg PS Ritch (1987) ArticleTitleEfficacy of oral administration of etidronate disodium in maintaining normal serum calcium levels in previously hypercalcemic cancer patients. Clin Ther 9 1–7
SH Ralston (1994) ArticleTitlePathogenesis and management of cancer-associated hypercalcemia. Cancer Surveys 21 179–196 Occurrence Handle1:CAS:528:DyaK2MXosVCnu70%3D Occurrence Handle8564993
R Gucalp P Ritch PH Wiernik et al. (1992) ArticleTitleComparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 10 134–142 Occurrence Handle1:STN:280:By2D1M3gsFA%3D Occurrence Handle1727915
GL Plosker KL Goa (1994) ArticleTitleClodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease [Review]. Drugs 47 945–982 Occurrence Handle1:STN:280:ByuA28vitlI%3D Occurrence Handle7521833
OP Purohit CR Radstone C Anthony JA Kanis RE Coleman (1995) ArticleTitleA randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcemia of malignancy. Br J Cancer 72 1289–1293 Occurrence Handle1:CAS:528:DyaK28XktV2jsg%3D%3D Occurrence Handle7577484
NP O’Rourke EV McCloskey S Vasikaran K Eyres D Fern JA Kanis (1993) ArticleTitleEffective treatment of maligant hypercalcemia with a single intravenous infusion of clodronate. Br J Cancer 67 560–563 Occurrence Handle1:STN:280:ByyC2snmvFw%3D Occurrence Handle8439504
J Rastad L Benson H Johansson M Knuutila B Pettersson C Wallfelt G Akerstrom S Ljunghall (1987) ArticleTitleClodronate treatment in patients with malignancy-associated hypercalcemia. Acta Med Scand 221 489–494 Occurrence Handle1:STN:280:BiiB28nosVQ%3D Occurrence Handle2955674
S Adami GP Bolzicco A Rizzo G Salvagno F Bertoldo M Rossini R Suppi V Lo Cascio (1987) ArticleTitleThe use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy. Bone Miner 2 395–404
JJ Body A Magritte F Seraj JP Sculier A Borkowski (1989) ArticleTitleAminohydroxypropylidene bisphosphonate (APD) treatment for tumor-associated hypercalcemia: a randomized comparison between a 3-day treatment and single 24-hour infusions. J Bone Miner Res 4 923–928
JJ Body M Pot A Borkowski JP Sculier J Klastersky (1987) ArticleTitleDose-response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia. Am J Med 82 957–963 Occurrence Handle1:STN:280:BiiB3M%2FivFI%3D Occurrence Handle3578365
JJ Body A Borkowski A Cleeren OLM Bijvoet (1986) ArticleTitleTreatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate. J Clin Oncol 4 1177–1183 Occurrence Handle1:STN:280:BimB1c%2FmtFA%3D Occurrence Handle3016205
SR Nussbaum J Younger CJ VandePol RF Gagel MA Zubler R Chapman IC Henderson LE Mallette (1993) ArticleTitleSingle-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages. Am J Med 95 297–304 Occurrence Handle1:STN:280:ByyA2sjmvVI%3D Occurrence Handle8368227
SH Ralston AA Alzaid SJ Gallacher MD Gardner RA Cowan IT Boyle (1988) ArticleTitleClinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcemia. Quart J Med 258 825–834
SH Ralston MD Gardner FJ Dryburgh AS Jenkins RA Cowan IT Boyle (1985) ArticleTitleComparison of aminohydroxypropylidene diphosphonate, mithramycin and corticosteroids/calcitonin in treatment of cancer-associated hypercalcemia. Lancet ii 907–910 Occurrence Handle10.1016/S0140-6736(85)90848-7
HP Sleeboom OLM Bijvoet AT Van Oosterom JH Gleed JLH O’Riordan (1983) ArticleTitleComparison of intravenous (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate and volume repletion in tumour-induced hypercalcemia. Lancet ii 239–243 Occurrence Handle10.1016/S0140-6736(83)90231-3
J Walls WA Ratcliffe A Howell NJ Bundred (1994) ArticleTitleResponse to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein. Br J Cancer 70 169–172 Occurrence Handle1:STN:280:ByuB1cbis1E%3D Occurrence Handle8018531
B Thurlimann R Waldburger HJ Senn D Thiebaud (1992) ArticleTitlePlicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial [see comments]. Ann Oncol 3 619–623 Occurrence Handle1:STN:280:ByyD1c7jt1E%3D Occurrence Handle1450043
C Wuster KH Schoter D Thiebaud C Manegold D Krahl MR Clemens M Ghielmini P Jaeger SH Scharla (1993) ArticleTitleMethylpentylaminopropylidene bisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia. Bone Miner 22 77–85
SH Ralston D Thiebaud Z Herrmann et al. (1997) ArticleTitleDose-response study of ibandronate in the treatment of cancer-associated hypercalcemia. Br J Cancer 75 295–300 Occurrence Handle1:CAS:528:DyaK2sXhtFGksLk%3D Occurrence Handle9010041
R Rizzoli D Thiebaud N Bundred et al. (1999) ArticleTitleSerum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy. J Clin Endocrinol Metab 84 3545–3550 Occurrence Handle1:CAS:528:DyaK1MXms1Oht7s%3D Occurrence Handle10522993
JJ Body A Lortholary G Romieu AM Vigneron J Ford (1999) ArticleTitleA dose-finding study of zoledronate in hypercalcemic cancer patients. J Bone Miner Res 14 1557–1561
P Major A Lortholary J Hon E Abdi G Mills HD Menssen F Yunus R Bell J Body E Quebe-Fehling J Seaman (2001) ArticleTitleZoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 19 558–567 Occurrence Handle1:CAS:528:DC%2BD3MXhtVektLk%3D Occurrence Handle11208851
SH Ralston AA Alzaid MD Gardner IT Boyle (1986) ArticleTitleTreatment of cancer-associated hypercalcemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J 292 1549–1550 Occurrence Handle1:STN:280:BimB2cvgvVU%3D
D Thiebaud AF Jaquet P Burckhardt (1990) ArticleTitleFast and effective treatment of malignant hypercalcemia: combination of suppositories of calcitonin and a single infusion of 3-amino-1-hydroxypropylidene-1-bisphosphonate. Arch Intern Med 150 2125–2128 Occurrence Handle10.1001/archinte.150.10.2125 Occurrence Handle1:STN:280:By6D38vktlA%3D Occurrence Handle2222097
CP Perlia NJH Gubisch J Wolter D Edelberg DD Dederick SG Taylor (1970) ArticleTitleMithramycin treatment of hypercalcemia. Cancer 25 389–394 Occurrence Handle1:STN:280:CS%2BC3cnotlI%3D Occurrence Handle5413510
GR Mundy R Wilkinson DA Heath (1983) ArticleTitleComparative study of the available medical therapy for hypercalcemia of malignancy. Am J Med 74 421–432 Occurrence Handle1:STN:280:BiyC2cbptFA%3D Occurrence Handle6219578
DH Fulmer AB Dimich EO Rothschild WPL Myers (1972) ArticleTitleTreatment of hypercalcemia: comparison of intravenously administered phosphate, sulphate and hydrocortisone. Arch Intern Med 129 923–930 Occurrence Handle10.1001/archinte.129.6.923 Occurrence Handle1:STN:280:CS2B3crnvVU%3D Occurrence Handle5033287
RI Breuer J Le Bauer (1967) ArticleTitleCaution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab 27 695–698 Occurrence Handle1:CAS:528:DyaF2sXkt1Snu7k%3D Occurrence Handle6025473
LJ Deftos R Neer (1974) ArticleTitleMedical management of the hypercalcemia of malignancy. Annu Rev Med 25 323–331 Occurrence Handle10.1146/annurev.me.25.020174.001543 Occurrence Handle1:CAS:528:DyaE2cXltFChtbk%3D Occurrence Handle4277568
RP Warrell Jr WK Murphy P Schulman PJ O’Dwyer G Heller (1991) ArticleTitleA randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia. J Clin Oncol 9 1467–1475 Occurrence Handle1:STN:280:By6A3czitVU%3D Occurrence Handle1906532
PJ Miach JK Dawborn TJ Martin et al. (1975) ArticleTitleManagement of the hypercalcemia of malignancy by peritoneal dialyssi. Med J Aust 1 782–784 Occurrence Handle1:STN:280:CSqB3MrpsFI%3D Occurrence Handle1152762
PL Selby M Davies JS Marks EB Mawer (1995) ArticleTitleVitamin D intoxication causes hypercalcemia by increased bone resorption which responds to pamidronate. Clin Endocrinol 43 531–536 Occurrence Handle1:CAS:528:DyaK28Xps1Wn
CJ Williams RA Smith RJ Ball H Wilkinson (1997) ArticleTitleHypercalcaemia in osteogenesis imperfecta treated with pamidronate [see comments]. Arch Dis Child 76 169–170 Occurrence Handle1:STN:280:ByiB387is1w%3D Occurrence Handle9068314
AJP Yates TH Jones KI Mundy RV Hague CB Brown D Guilland-Cumming JA Kanis (1984) ArticleTitleImmobilisation hypercalcemia in adults and treatment with clodronate. Br Med J 289 1111–1112 Occurrence Handle1:STN:280:BiqD38vhtlA%3D
SJ Gallacher SH Ralston FJ Dryburgh FC Logue BF Allam BF Boyce IT Boyle (1990) ArticleTitleImmobilisation-related hypercalcemia—a possible novel mechanism and response to pamidronate. Postgrad Med J 66 918–922 Occurrence Handle1:STN:280:By6D1MrivF0%3D Occurrence Handle2267202
HD McIntyre DP Cameron SM Urquhart WE Davies (1989) ArticleTitleImmobilization hypercalcemia responding to intravenous pamidronate therapy. Postgrad Med J 65 244–246 Occurrence Handle1:STN:280:By%2BD1c3ptVc%3D Occurrence Handle2594602
D Kedlaya ME Brandstater JK Lee (1998) ArticleTitleImmobilization hypercalcemia in incomplete paraplegia: successful treatment with pamidronate. Arch Phys Med Rehab 79 222–225 Occurrence Handle1:STN:280:DyaK1c7jsVarsQ%3D%3D
CJ Gibbs M Peacock (1986) ArticleTitleHypercalcemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J 62 937–938 Occurrence Handle1:STN:280:BiiD2c7itlU%3D Occurrence Handle3774726
JS Adams (1999) Hypercalcemia due to granuloma forming disorders. MJ Favus (Eds) Primer on the metabolic bone diseases and disorders of mineral metabolism. Kluwer Philadelphia 212–214
JS Adams MM Diz OP Sharma (1989) ArticleTitleEffective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111 437–438
JS Adams OP Sharma MM Diz DB Endres (1990) ArticleTitleKetoconazole decreases the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia. J Clin Endocrinol Metab 70 1090–1095 Occurrence Handle1:STN:280:By%2BB3czhtlM%3D Occurrence Handle2318934
SJ Silverberg E Shane TP Jacobs E Siris JP Bilezikian (1999) ArticleTitleA 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341 1249–1255 Occurrence Handle10.1056/NEJM199910213411701 Occurrence Handle1:STN:280:DyaK1Mvkt1alug%3D%3D Occurrence Handle10528034
CA Reasner MD Stone DJ Hosking A Ballah GR Mundy (1993) ArticleTitleAcute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate. J Clin Endocrinol Metab 77 1067–1071 Occurrence Handle1:CAS:528:DyaK2cXjvFA%3D Occurrence Handle8408454
RA Evans (1987) ArticleTitleAminohydroxypropylidene diphosphonate treatment of hypercalcemic crisis due to primary hyperparathyroidism. Aust NZ J Med 17 58–59 Occurrence Handle1:STN:280:BiiB1MfhslA%3D
NAT Hamdy RES Gray E McCloskey J Galloway JM Rattenbury CB Brown JA Kanis (1987) ArticleTitleClodronate in the medical management of hyperparathyroidism. Bone 8 IssueIDsuppl 1 s69–s77 Occurrence Handle2961358
E Shane DC Baquiran JP Bilezikian (1981) ArticleTitleEffects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism. Ann Intern Med 95 23–27
FJM van Breukelen OLM Bijvoet WB Frijlink HP Sleeboom H Mulder AT Van Oosterom (1982) ArticleTitleEfficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: observations on regulation of serum calcium. Calcif Tissue Int 34 321–327 Occurrence Handle1:STN:280:BiyD2M%2Fis1Q%3D Occurrence Handle6814719
SJ Silverberg JP Bilezikian HG Bone GB Talpos MJ Horwitz AF Stewart (1999) ArticleTitleTherapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 84 2275–2285 Occurrence Handle1:CAS:528:DyaK1MXks1agt7s%3D Occurrence Handle10404790
AF Stewart (1999) Miscellaneous causes of hypercalcemia. MJ Favus (Eds) Primer on the metabolic bone diseases and disorders of mineral metabolism. Kluwer Philadelphia 215–219
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ralston, S., Coleman, R., Fraser, W. et al. Medical Management of Hypercalcemia . Calcif Tissue Int 74, 1–11 (2004). https://doi.org/10.1007/s00223-001-1135-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-001-1135-6